ArticleScientific reports2025
Analysis of aperiodic activity in obsessive-compulsive disorder and major depression.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Gamma and beta power and the 1/f slope vary across a spectrum of depression severity.Translational psychiatry · 2026Article
- Scale-Free Neurodynamics as Functional Fingerprint of Brain Regions.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Obsessive-compulsive disorder (OCD) is believed to be linked to alterations in the cortical excitation-inhibition (E/I) ratio. Recent studies highlight aperiodic EEG activity as a neurophysiological marker for E/I ratio. We investigated the role of aperiodic activity during resting-state EEG in a children and adolescents sample of OCD patients (n = 38), compared to healthy controls (HC) (n = 94) and patients with major depression (MDD) (n = 88). To quantify aperiodic activity in resting-state EEG, we employed the FOOOF (Fitting Oscillations & One Over F) algorithm, which extracts the aperiodic exponent from EEG data. Compared to HC, both OCD and MDD patients exhibited increased E/I ratio as shown by decreased aperiodic exponents. Controlling for age by cohort-matching and for medication and stimulant intake on the test day rendered the statistical outcome non-significant but left the qualitative pattern of the outcomes intact. We conclude that both MDD and OCD seem to come with increased E/I ratios, as indicated by the aperiodic exponent, even though this effect may be moderated by age in OCD. This renders the aperiodic exponent a promising neural marker for psychopathology. However, the absence of a significant difference between OCD and MDD indicates that this marker may not be sensitive enough to differentiate between particular psychopathologies, which may be due to the fact that they often co-exist. The potential of using aperiodic exponents to examine the effectiveness of treatments in developmental neuropsychiatry should be explored. This approach should be carefully evaluated in future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.